EcoR1 Capital, LLC
29 holdingsFiling period: 2026-03-31Current AUM: $2.62Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ZYME | ZYMEWORKS INC | 22.97M | $575.2M | $504.0M | 19.23% | -- | 2026-03-31 |
| 2 | ANAB | ANAPTYSBIO INC | 7.88M | $437.0M | $420.5M | 16.04% | -- | 2026-03-31 |
| 3 | — | JAZZ PHARMACEUTICALS PLC | 1.71M | $322.6M | $322.6M | 12.31% | -- | 2026-03-31 |
| 4 | CNTA | CENTESSA PHARMACEUTICALS PLC | 6.41M | $254.6M | $254.6M | 9.72% | +3.30M | 2026-03-31 |
| 5 | CRNX | CRINETICS PHARMACEUTICALS IN | 4.29M | $155.7M | $358.1M | 13.67% | -- | 2026-03-31 |
| 6 | AKTS | AKTIS ONCOLOGY INC | 4.82M | $86.3M | $106.5M | 4.06% | -- | 2026-03-31 |
| 7 | ORIC | ORIC PHARMACEUTICALS INC | 6.73M | $85.2M | $74.5M | 2.84% | -- | 2026-03-31 |
| 8 | CGON | CG ONCOLOGY INC | 1.10M | $74.6M | $78.5M | 2.99% | +37.2K | 2026-03-31 |
| 9 | — | CRISPR THERAPEUTICS AG | 1.39M | $66.1M | $66.1M | 2.52% | -- | 2026-03-31 |
| 10 | ETON | ETON PHARMACEUTICALS INC | 2.17M | $53.6M | $100.8M | 3.85% | +141.4K | 2026-03-31 |
| 11 | GLPG | GALAPAGOS NV | 1.67M | $50.0M | $50.0M | 1.91% | -- | 2026-03-31 |
| 12 | XNCR | XENCOR INC | 2.18M | $26.3M | $44.1M | 1.68% | -1,135,612 | 2026-03-31 |
| 13 | NGNE | NEUROGENE INC | 1.27M | $25.6M | $41.8M | 1.60% | -- | 2026-03-31 |
| 14 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2.82M | $25.3M | $22.8M | 0.87% | -- | 2026-03-31 |
| 15 | MBX | MBX BIOSCIENCES INC | 777.0K | $23.2M | $51.2M | 1.95% | -1,346,604 | 2026-03-31 |
| 16 | RLAY | RELAY THERAPEUTICS INC | 1.90M | $19.0M | $35.9M | 1.37% | -- | 2026-03-31 |
| 17 | ZBIO | ZENAS BIOPHARMA INC | 789.5K | $15.4M | $24.8M | 0.95% | -- | 2026-03-31 |
| 18 | ERAS | ERASCA INC | 900.0K | $14.6M | $16.3M | 0.62% | -- | 2026-03-31 |
| 19 | EIKN | EIKON THERAPEUTICS INC | 732.6K | $7.8M | $6.7M | 0.26% | -- | 2026-03-31 |
| 20 | REPL | REPLIMUNE GROUP INC | 1.00M | $7.7M | $11.2M | 0.43% | -- | 2026-03-31 |
| 21 | — | ZURA BIO LTD | 1.18M | $7.0M | $7.0M | 0.27% | -- | 2026-03-31 |
| 22 | PHAT | PHATHOM PHARMACEUTICALS INC | 625.0K | $6.9M | $5.5M | 0.21% | -- | 2026-03-31 |
| 23 | MREO | MEREO BIOPHARMA GROUP PLC | 13.37M | $4.4M | $4.6M | 0.17% | +5.51M | 2026-03-31 |
| 24 | STOK | STOKE THERAPEUTICS INC | 100.0K | $3.3M | $2.9M | 0.11% | -- | 2026-03-31 |
| 25 | PRLD | PRELUDE THERAPEUTICS INC | 947.0K | $3.2M | $4.4M | 0.17% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2